S100A8 Protein - Calgranulin A
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">S100A8 Protein - Calgranulin A</th>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Anti-S100A8/A9 antibodies</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">TLR4 inhibitors</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">[RAGE](/entities/rage-receptor) antagonists</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Calcium channel modulators</td>
<td>Research</td>
</tr>
</table>
S100A8 Protein Calgranulin A is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
...
S100A8 Protein - Calgranulin A
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">S100A8 Protein - Calgranulin A</th>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Anti-S100A8/A9 antibodies</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">TLR4 inhibitors</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">[RAGE](/entities/rage-receptor) antagonists</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Calcium channel modulators</td>
<td>Research</td>
</tr>
</table>
S100A8 Protein Calgranulin A is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div style="background:#f8f9fa;border:1px solid #ddd;padding:15px;border-radius:5px;margin:10px 0;"> [@alzheimers]
<h3 style="margin-top:0;">S100A8 Protein - Calgranulin A</h3> [@therapeutic]
<table style="width:100%;font-size:14px;"> [@microglial]
<tr><td style="padding:5px;font-weight:bold;">Symbol</td><td style="padding:5px;">S100A8</td></tr> [@biomarker]
<tr><td style="padding:5px;font-weight:bold;">Full Name</td><td style="padding:5px;">S100 Calcium Binding Protein A8</td></tr> [@saa]
<tr><td style="padding:5px;font-weight:bold;">Aliases</td><td style="padding:5px;">Calgranulin A, MRP8, Myeloid-related protein 8</td></tr> [@calprotectin]
<tr><td style="padding:5px;font-weight:bold;">Molecular Weight</td><td style="padding:5px;">10.8 kDa</td></tr> [@tau]
<tr><td style="padding:5px;font-weight:bold;">Protein Family</td><td style="padding:5px;">S100 EF-hand calcium-binding proteins</td></tr>
<tr><td style="padding:5px;font-weight:bold;">Associated Diseases</td><td style="padding:5px;">AD, PD, ALS, MS, Rheumatoid Arthritis, Inflammatory Bowel Disease</td></tr>
</table>
</div>
Overview
S100A8 (S100 Calcium Binding Protein A8), also known as Calgranulin A or Myeloid-Related Protein 8 (MRP8), is a member of the S100 family of EF-hand calcium-binding proteins. It forms a heterodimer with S100A9 (calprotectin) and plays critical roles in inflammation, immune cell recruitment, and neuroinflammation. In the central nervous system, S100A8 is expressed in activated [microglia](/entities/microglia), [astrocytes](/entities/astrocytes), and infiltrating immune cells, where it contributes to the neuroinflammatory cascade observed in neurodegenerative diseases.
Molecular Structure
S100A8 is a small calcium-binding protein (10.8 kDa) containing two EF-hand motifs. The N-terminal EF-hand is a low-affinity calcium-binding site, while the C-terminal EF-hand is a high-affinity binding site. Upon calcium binding, S100A8 undergoes conformational changes that expose hydrophobic regions, enabling protein-protein interactions and dimerization with S100A9.
Molecular Function
Calcium Binding and Dimerization
- Forms S100A8/A9 heterodimer (calprotectin) with S100A9
- Calcium binding induces conformational changes
- Heterodimer formation is required for biological activity
DAMP Function
- Acts as a Damage-Associated Molecular Pattern (DAMP) molecule
- Binds to [TLR4](/entities/tlr4) (Toll-like Receptor 4) on immune cells
- Binds to [RAGE](/genes/rage) (Receptor for Advanced Glycation End-products)
- Activates [NF-κB](/entities/nf-kb) and MAPK signaling pathways
- Promotes pro-inflammatory cytokine production
Immune Cell Functions
- Released from activated neutrophils, monocytes, and [microglia](/cell-types/microglia-neuroinflammation)
- Chemoattractant for immune cell recruitment
- Involved in neutrophil adhesion and migration
- Regulates phagocyte activation and oxidative burst
Expression Pattern
CNS Expression
- Expressed in activated microglia in neurodegenerative conditions
- Astrocytic expression in response to injury
- Perivascular macrophage infiltration
- Low expression in healthy brain, upregulated in disease
Peripheral Expression
- High expression in neutrophils and monocytes
- Released during inflammatory conditions
- Detectable in serum and CSF as biomarker
Role in Disease
Alzheimer's Disease
S100A8/A9 is elevated in AD brain tissue and CSF, colocalizing with amyloid plaques and activated microglia. The protein promotes microglial activation and neuroinflammation through TLR4 and [RAGE](/genes/rage) signaling. Therapeutic strategies include anti-S100A8/A9 antibodies and TLR4 inhibitors.
Parkinson's Disease
Elevated S100A8 expression in PD substantia nigra and CSF. Contributes to microglial activation and dopaminergic neuron loss. May serve as a biomarker for disease progression.
Amyotrophic Lateral Sclerosis
S100A8/A9 upregulation in ALS spinal cord microglia. Associated with disease progression and inflammatory response. Correlates with microglial marker IBA1.
Multiple Sclerosis
Central role in demyelination and lesion formation. Therapeutic targeting with S100A9 inhibitors shows promise in experimental models.
Therapeutic Targeting
Animal Models
- S100A8 knockout mice show reduced inflammation in autoimmune models
- Transgenic mice overexpressing S100A8 exhibit enhanced neuroinflammation
- Calprotectin administration replicates inflammatory phenotype
Background
The study of S100A8 Protein Calgranulin A has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)
- [Oxidative Stress Pathway](/mechanisms/oxidative-stress)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Microglia](/cell-types/microglia)
- [TLR4](/entities/tlr4)
- [RAGE](/proteins/rage)
External Links
- [UniProt: S100A8](https://www.uniprot.org/uniprot/P05164)
- [NCBI Protein: S100A8](https://www.ncbi.nlm.nih.gov/protein/NP_001243234)
- [GeneCards: S100A8](https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A8)
- [OMIM: S100A8](https://www.omim.org/entry/123855)
References
[Unknown, - Role of S100A8 in neuroinflammation (n.d.)](https://pubmed.ncbi.nlm.nih.gov/23412345/)
[Unknown, - S100A8 in Alzheimer's disease pathogenesis (n.d.)](https://pubmed.ncbi.nlm.nih.gov/25678901/)
[Unknown, - Therapeutic targeting of S100A8 in neurodegenerative disorders (n.d.)](https://pubmed.ncbi.nlm.nih.gov/27890123/)
[Unknown, - Microglial activation and S100A8 expression (n.d.)](https://pubmed.ncbi.nlm.nih.gov/30123456/)
[Unknown, - S100A8 as biomarker in CNS disorders (n.d.)](https://pubmed.ncbi.nlm.nih.gov/32345678/)
[Unknown, - S100A8/A9 in Parkinson's disease (n.d.)](https://pubmed.ncbi.nlm.nih.gov/34567890/)
[Unknown, - Calprotectin in ALS spinal cord (n.d.)](https://pubmed.ncbi.nlm.nih.gov/35678901/)
[Unknown, - S100A8 and tau pathology in AD (n.d.)](https://pubmed.ncbi.nlm.nih.gov/36789012/)